Collectively, combined treatment with Man@pSiNPs‐erastin and anti‐PD‐L1 substantially impeded tumor progression by suppressing TAM infiltration, reducing the M2‐like shift, and enhancing antitumor immunity of the body. The gene discussed is CD274; the disease is neoplasm.